» Articles » PMID: 27267365

Low-grade Sulfadoxine-pyrimethamine Resistance in Plasmodium Falciparum Parasites from Lubango, Angola

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2016 Jun 9
PMID 27267365
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Malaria is a major parasitic disease, affecting millions of people in endemic areas. Plasmodium falciparum parasites are responsible for the most severe cases and its resistance to anti-malarial drugs is notorious. This is a possible obstacle to the effectiveness of intermittent preventive treatment (IPT) based on sulfadoxine-pyrimethamine (SP) cures administrated to pregnant women (IPTp) during their pregnancy. As this intervention is recommended in Angola since 2006, it has assessed, in this country, the molecular profiles in P. falciparum dhfr and dhps, two polymorphic genes associated to pyrimethamine and sulfadoxine resistance, respectively.

Methods: Blood samples from 52 falciparum patients were collected in Lubango, Angola and pfdhfr and pfdhps polymorphisms were analysed using nested-PCR and DNA sequencing.

Results: In the pfdhfr gene, the 108N mutation was almost fixed (98 %), followed by 59R (63 %), 51I (46 %), 50R and 164L (2 %, respectively). No 16V/S mutations were found. The most common double mutant genotype was CNRN (59 + 108; 46 %), followed by CICN (51 + 108; 29 %) whereas IRN (51 + 59 + 108; 15 %), CNRNVL (59 + 108 + 164; 2 %) and RICN (50 + 51 + 108; 2 %) triple mutant genotypes were detected. Investigations of the pfdhps gene showed that the 437G mutation was the most prevalent (97 %). Only two and one samples disclosed the 540E (7 %) and the 436A (3 %), respectively. Single mutant SGKAA (437; 86 %) was higher than SGEAA (437 + 540; 7 %) or AGKAA (436 + 437; 3 %) double mutants genotypes. No polymorphism was detected at codons 581G and 613T/S. Combining pfdhfr and pfdhps alleles two triple mutant haplotypes (double mutant in dhfr and single mutant in dhps) were observed: the ACICNVI/SGKAA in 14 (56 %) samples and the ACNRNVI/SGKAA in five (20 %) samples. One quadruple mutant haplotype was detected (ACIRNVI/SGKAA) in six (24 %) P. falciparum samples. No quintuple pfdhfr-pfdhps mutant was noted.

Conclusion: pfdhfr and pfdhps gene mutations in isolates from Lubango are suggestive of a low-grade SP resistance and IPT for pregnant women and infant based on SP treatment could be effective. Routine molecular studies targeting polymorphism in these two genes need to be routinely conducted at country level.

Citing Articles

Antimalarial Drug Resistance: A Brief History of Its Spread in Indonesia.

Fitri L, Pawestri A, Winaris N, Endharti A, Khotimah A, Abidah H Drug Des Devel Ther. 2023; 17:1995-2010.

PMID: 37431492 PMC: 10329833. DOI: 10.2147/DDDT.S403672.


Assessment of genetic polymorphisms associated with malaria antifolate resistance among the population of Libreville, Gabon.

Dinzouna-Boutamba S, Iroungou B, Akombi F, Yacka-Mouele L, Moon Z, Aung J Malar J. 2023; 22(1):183.

PMID: 37312220 PMC: 10265907. DOI: 10.1186/s12936-023-04615-1.


Global Analysis of Dihydropteroate Synthase Variants Associated with Sulfadoxine Resistance Reveals Variant Distribution and Mechanisms of Resistance: A Computational-Based Study.

Boateng R, Myers-Hansen J, Dolling N, Mensah B, Brodsky E, Mazumder M Molecules. 2023; 28(1).

PMID: 36615340 PMC: 9822128. DOI: 10.3390/molecules28010145.


Molecular Determinants of Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum Isolates from Central Africa between 2016 and 2021: Wide Geographic Spread of Highly Mutated and Alleles.

Wang X, Zhang X, Chen H, Lu Q, Ruan W, Chen Z Microbiol Spectr. 2022; 10(5):e0200522.

PMID: 36121226 PMC: 9602997. DOI: 10.1128/spectrum.02005-22.


Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola.

Ebel E, Reis F, Petrov D, Beleza S Malar J. 2021; 20(1):175.

PMID: 33827587 PMC: 8028775. DOI: 10.1186/s12936-021-03713-2.


References
1.
McCollum A, Poe A, Hamel M, Huber C, Zhou Z, Shi Y . Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis. 2006; 194(2):189-97. DOI: 10.1086/504687. View

2.
Griffin J, Cairns M, Ghani A, Roper C, Schellenberg D, Carneiro I . Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One. 2010; 5(9):e12618. PMC: 2935388. DOI: 10.1371/journal.pone.0012618. View

3.
Certain L, Briceno M, Kiara S, Nzila A, Watkins W, Sibley C . Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006. J Infect Dis. 2008; 197(12):1743-51. PMC: 2680814. DOI: 10.1086/588198. View

4.
Oesterholt M, Alifrangis M, Sutherland C, Omar S, Sawa P, Howitt C . Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya. PLoS One. 2009; 4(2):e4364. PMC: 2632751. DOI: 10.1371/journal.pone.0004364. View

5.
Venkatesan M, Alifrangis M, Roper C, Plowe C . Monitoring antifolate resistance in intermittent preventive therapy for malaria. Trends Parasitol. 2013; 29(10):497-504. PMC: 3810209. DOI: 10.1016/j.pt.2013.07.008. View